Advisory Board Members

Frank Scorpiniti

CEO, Rexall Pharma Plus

Scorpiniti is the chief executive officer of Katz Group Canada Ltd. An accomplished leader in retail pharmacy, Scorpiniti has over 20 years experience in North American chain drug retail.

He was appointed to his current role in February 2012. Scorpiniti joined Katz Group in April 2011 as CEO. Prior to Katz Group, Scorpiniti was SVP, pharmacy operations, Duane Reade, a New York-based chain. During his tenure, he was integral in driving transformative change for the organization including developing strategy for the rebranding of the pharmacy experience and championing a pharmacy-focused customer experience. Scorpiniti joined Duane Reade after holding several senior level positions at Longs Drug Stores, a U.S.-based west coast regional pharmacy chain where he started his career. Scorpiniti’s industry contributions focus on expanded pharmacy care and strengthening the relationship between pharmaceutical manufacturers and pharmacy. He is a member of the Board of Governors for GS1 Canada, a director of the National Association of Chain Drug Stores (NACDS) and was appointed as the chairman of the board of the Canadian Association of Chain Drug Stores (CACDS) in November, 2012. Scorpiniti graduated with a Doctorate of Pharmacy (Pharm D) from the University of Pacific, School of Pharmacy, in Stockton, California. Katz Group Canada Ltd. is committed to providing pharmacy care excellence in retail drug pharmacy and specialty pharmacy environments. Focused on improving the health of Canadians, its flagship national chain, Rexall, is among the most trusted names in pharmacy with a heritage of caring for the health of Canadians dating back to 1904.